BAB, Inc. Announces Cash Distribution

BAB, Inc. Announces Cash Distribution GlobeNewswire December 09, 2025 Deerfield, Ill., Dec. 09, 2025 (GLOBE NEWSWIRE) — BAB, Inc. (OTCQB: BABB), today announced that its Board of Directors has declared a distribution of two cents ($0.02) per share, consisting of a quarterly distribution of one cent ($0.01) per share and a special distribution of one […]

FullPAC Announces Qualification of Regulation A+ Offering

Plans to List on Nasdaq Under Ticker Symbol “GOTV” to Capitalize on Record-Breaking 2026 Election Spend GOTV to Become the First Pure-Play Public Campaign Technology Platform Positioned for Hyper-Growth VIRGINIA BEACH, VA, Dec. 09, 2025 (GLOBE NEWSWIRE) — FullPAC, Inc., (“FullPAC” or the “Company”), a leading nonpartisan campaign technology provider trusted by over 5,000 U.S.

FullPAC Announces Qualification of Regulation A+ Offering

FullPAC Announces Qualification of Regulation A+ Offering GlobeNewswire December 09, 2025 Plans to List on Nasdaq Under Ticker Symbol “GOTV” to Capitalize on Record-Breaking 2026 Election Spend GOTV to Become the First Pure-Play Public Campaign Technology Platform Positioned for Hyper-Growth VIRGINIA BEACH, VA, Dec. 09, 2025 (GLOBE NEWSWIRE) — FullPAC, Inc., (“FullPAC” or the “Company”),

Westchester Medical Center and Good Samaritan Hospital Recognized as Top Maternity Hospitals by U.S. News & World Report

U.S. News & World Report (U.S. News) has namedWestchester Medical Centerand Good Samaritan Hospital among the nation's top hospitals for maternity care in its 2026 ratings – the highest distinction available in the publication's annual Best Hospitals for Maternity Care study. “Patients are counting on us at the most profound moments of their lives, and

Flex Partners with Ladder to Make Strength Training Eligible for HSA and FSA Spending

SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Ladder, the #1 iOS app for strength training, has partnered with Flex, the leading HSA/FSA infrastructure company, to make it easier than ever for consumers to invest in their health and fitness with pre-tax dollars. Through this partnership, individuals can now use their HSA and FSA funds

Flex Partners with Ladder to Make Strength Training Eligible for HSA and FSA Spending

Flex Partners with Ladder to Make Strength Training Eligible for HSA and FSA Spending The new integration allows consumers to use pre-tax health benefits on Ladder's expert-led strength training programs, expanding access to affordable, effective fitness plans. GlobeNewswire December 09, 2025 SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Ladder, the #1 iOS app for

Kidney Damage from COVID Vaccines Is Easily Missed, according to the Journal of American Physicians and Surgeons

TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) — Initial symptoms of lethal chronic kidney disorder are vague and hard to recognize. Therefore, the long-term nephrotoxicity of COVID-19 vaccine can elude early detection, writes Jane Orient, M.D., in the winter issue of the Journal of American Physicians and Surgeons. This diagnostic blind spot has been widened

GATES USA SPAH Strengthens Customer Support and Capabilities with Arrival of First GEnx Engine

GA Telesis Engine Services, GATES USA SPAH, a joint venture between GA Telesis and Air Transport Services Group, Inc., located in Wilmington, OH, has once again expanded its capabilities by welcoming its first GEnx Engine to the facility. https://mma.prnewswire.com/media/1023925/GA_Telesis_LLC_Logo.jpg Strategically located in Wilmington, Ohio, the USA SPAH facility leverages its relevant proximity to deliver industry-leading

Kidney Damage from COVID Vaccines Is Easily Missed, according to the Journal of American Physicians and Surgeons

Kidney Damage from COVID Vaccines Is Easily Missed, according to the Journal of American Physicians and Surgeons GlobeNewswire December 09, 2025 TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) — Initial symptoms of lethal chronic kidney disorder are vague and hard to recognize. Therefore, the long-term nephrotoxicity of COVID-19 vaccine can elude early detection, writes Jane

Immunostimulant Market to Reach $288.82 billion, Globally, by 2034 at 9.9% CAGR: Allied Market Research

Immunostimulant therapies are widely used across preventive care, acute care, and chronic disease management owing to their ability to enhance or modulate the body's immune response. These products, which include vaccines, cytokines, monoclonal antibodies, and immunomodulatory agents, are specifically developed to strengthen immunity, improve pathogen resistance, and support treatment outcomes in infectious diseases, oncology, autoimmune

Scroll to Top